Volume 94, Issue 7

Search all Annals of Hematology articles

July 2015

Filter by

Volume:

Sort by

Date published:

New to old Old to new

28 articles in this issue

MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
Ciprian Tomuleasa
Shigeo Fuji
Hermann Einsele
Review Article 22 April 2015 Pages: 1081 - 1092
Krüppel-like factor 1 mutations and expression of hemoglobins F and A₂ in homozygous hemoglobin E syndrome
Wanicha Tepakhan
Supawadee Yamsri
Supan Fucharoen
Original Article 20 February 2015 Pages: 1093 - 1098
Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major
Munevver Bas
Fatma Gumruk
Sule Unal
Original Article 06 March 2015 Pages: 1099 - 1104
The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia
Xin Zhao
Li Zhang
Fengkui Zhang
Original Article 19 March 2015 Pages: 1105 - 1110
Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis
Bakul I. Dalal
Alok P. Vakil
Luke Y. C. Chen
Original Article 25 March 2015 Pages: 1111 - 1117
Osteopontin: a potential biomarker of Gaucher disease
Filippo Vairo
Fernanda Sperb-Ludwig
Ida Schwartz
Original Article 01 April 2015 Pages: 1119 - 1125
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
Bruno C. Medeiros
Sacha Satram-Hoang
Carolina Reyes
Original Article Open access 20 March 2015 Pages: 1127 - 1138
Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
Nobuhiko Imahashi
Haruhiko Ohashi
for the Nagoya Blood and Marrow Transplantation Group
Original Article 15 February 2015 Pages: 1139 - 1148
Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives
Jury L. Shevchenko
Alexey N. Kuznetsov
Andrei A. Novik
Original Article 25 February 2015 Pages: 1149 - 1157
Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics
Satoshi Yamasaki
Goichi Yoshimoto
for the Fukuoka Blood and Marrow Transplantation Group
Original Article 24 February 2015 Pages: 1159 - 1165
Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
Milla Elvi Linnea Kuusisto
Kirsi-Maria Haapasaari
Outi Kuittinen
Original Article Open access 21 February 2015 Pages: 1167 - 1174
Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy
Xi-Wen Bi
Wen-Qi Jiang
Zhi-Ming Li
Original Article 17 February 2015 Pages: 1175 - 1184
Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML)
Su Kyung Jung
Ji Sun Paik
Seok-Goo Cho
Original Article 03 March 2015 Pages: 1185 - 1193
Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?
J. J. C. Stienen
P. B. Ottevanger
On behalf of the PEARL study group
Original Article Open access 15 March 2015 Pages: 1195 - 1203
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M³P)
K. M. Kortüm
C. Langer
Esteban Braggio
Original Article 07 March 2015 Pages: 1205 - 1211
Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses
Yona Nadir
Gleb Saharov
Tamar Shochat
Original Article 07 March 2015 Pages: 1213 - 1219
Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case
Tran B. Nguyen
Mamiko Sakata-Yanagimoto
Shigeru Chiba
Letter to the Editor 17 February 2015 Pages: 1221 - 1223
HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients
Philippe Saliou
Gérald Le Gac
Virginie Scotet
Letter to the Editor 06 March 2015 Pages: 1225 - 1227
Erythropoietin receptor mutation—a rush of blood to the head?
Andreas Holbro
Radek Skoda
Thomas Lehmann
Letter to the Editor 14 March 2015 Pages: 1229 - 1231
HLA-DRB1 mismatch is associated with a decreased relapse in adult acute myeloid leukemia after single-unit myeloablative cord blood transplantation
Takaaki Konuma
Seiko Kato
Satoshi Takahashi
Letter to the Editor 11 March 2015 Pages: 1233 - 1235
Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor
Joaquín Martinez-Lopez
Ana Jimenez
Rosa Ayala
Letter to the Editor 21 March 2015 Pages: 1237 - 1239
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman’s disease
Linus Angenendt
Andrea Kerkhoff
Wolfgang E. Berdel
Letter to the Editor 21 March 2015 Pages: 1241 - 1243
Retinal and central nervous system involvement in T cell large granular lymphocyte leukaemia
Carol Y. M. Cheung
Alvin H. W. Ip
Yok-Lam Kwong
Letter to the Editor 02 April 2015 Pages: 1245 - 1246
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab
Federico Simonetta
Magdalena Posa
Carlo Chizzolini
Letter to the Editor 07 April 2015 Pages: 1247 - 1249
CyberKnife radiosurgery leading to long-lasting complete remission in locally relapsed solitary plasmacytoma of the bone
Georg Theiler
Verena Schwetz
Helmut H. Schmidt
Letter to the Editor 10 April 2015 Pages: 1251 - 1253
De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML
S. Bartels
U. Lehmann
H. Kreipe
Letter to the Editor 14 April 2015 Pages: 1255 - 1256
Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment
Mark Plander
Tamás Szendrei
János L. Iványi
Letter to the Editor 15 April 2015 Pages: 1257 - 1258
Erratum to: A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers
Vivian Lobo
Shrimati Shetty
Kanjaksha Ghosh
Erratum 25 April 2015 Pages: 1259 - 1259

Volume 94, Issue 7

MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation

Krüppel-like factor 1 mutations and expression of hemoglobins F and A₂ in homozygous hemoglobin E syndrome

Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major

The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia

Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis

Osteopontin: a potential biomarker of Gaucher disease

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse

Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives

Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy

Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML)

Trends in quality of non-Hodgkin’s lymphoma care: is it getting better?

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M³P)

Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses

Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case

HFE hemochromatosis: influence of dietary iron intake on the iron overload of C282Y homozygous patients

Erythropoietin receptor mutation—a rush of blood to the head?

HLA-DRB1 mismatch is associated with a decreased relapse in adult acute myeloid leukemia after single-unit myeloablative cord blood transplantation

Myeloproliferative neoplasm in a thalassaemic patient: response to treatment with a JAK inhibitor

Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman’s disease

Retinal and central nervous system involvement in T cell large granular lymphocyte leukaemia

Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab

CyberKnife radiosurgery leading to long-lasting complete remission in locally relapsed solitary plasmacytoma of the bone

De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML

Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment

Erratum to: A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers

Navigation